1-3 of 3
Beatriz Colom Fernandez
Close
Sort by
Journal Articles

Efficacy and Safety of Dasatinib in Late Suboptimal Response CML Patients a Its Relation with Lymphocytosis, Lymphocyte Migration and Chemokine Receptor Expression

Valentín García-Gutierrez, Beatriz Colom-Fernandez, Anna Kreutzman, PhD, Luis Felipe Casado, Fermín Sánchez-Guijo, MD, Rosa M. Ayala, MD PhD, Concepcion Boque, PhD, Blanca Xicoy, MD PhD, Isabel Montero, MD, Cesar Soto, Raquel De Paz, Joaquin Martinez Lopez, MDPhD, Cecilia Muñoz-Calleja, Juan Luis Steegmann, MD
Journal: Blood
Blood (2015) 126 (23): 4015.
https://doi.org/10.1182/blood.V126.23.4015.4015
Published: 2015
Journal Articles

The Role of CMV Serostatus of the Donor in the Graft Lymphoid Composition and Prediction of Gvhd and CMV Reactivation

Anna Kreutzman, PhD, Itxaso Portero Sainz, MSc, Valle Gomez Garcia De Soria, MD PhD, Carlos Fernandez, MD, Royg Mercedes, MD, Ana Marcos, MSc, Beatriz Colom Fernandez, MSc, Ana Ramirez, Laura Cardeñoso, MD PhD, Rafael De La Camara, MD, Cecilia Muñoz Calleja, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2422.
https://doi.org/10.1182/blood.V124.21.2422.2422
Published: 2014
Journal Articles

NK-Cells In Dasatinib-Treated Chronic Myeloid Leukemia Patients Display a Unique Phenotype Associated With Cytotoxic Potential

Beatriz Colom Fernandez, Anna Kreutzman, PhD, Valentin Garcia, MD, PhD, Maria José Requena Rodríguez, MD, Raúl Córdoba Mascuñano, MD, Begoña Maestro Gutiérrez, Juan Luis Steegmann, MD, Cecilia Muñoz Calleja, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1475.
https://doi.org/10.1182/blood.V122.21.1475.1475
Published: 2013